Clinical Trial Update: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

View source ↗

Summary

This clinical trial update describes a study evaluating skin health and quality of life in patients receiving anti-PD-1/PD-L1/CTLA-4 inhibitors or CDK inhibitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Lung Cancer
• Melanoma
• Renal Cell Carcinoma
• Skin Cancer

Drugs mentioned

• Anti-PD-1/PD-L1/CTLA-4 inhibitors
• CDK inhibitors

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Lung Cancer, Breast Cancer | Status: RECRUITING